Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer.
BACKGROUND:Adjuvant endocrine treatment improves survival after estrogen receptor (ER) positive breast cancer. Recurrences occur, and most patients with metastatic breast cancer develop treatment resistance and incurable disease. An influential factor in relation to endocrine treatment resistance is...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science (PLoS)
2019-01-01
|
| Collection: | PLoS ONE |
| Accès en ligne: | https://doi.org/10.1371/journal.pone.0226150 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|